Founder · Kantesti Ltd · London & Naples
Julian Emir
One person. Fourteen products. Two million people who finally understood their blood test.
Bootstrapped since day one. No investors, no team, no exit plan.
- 2M+
- peoplehave uploaded a blood test and read it back in their own language.
- 127+
- countriesmost of them places no health product had bothered to localise for.
- 75+
- languagesnot translated interfaces, but each one built against its own laboratory reports.
- 0
- outside investmentno round, no board, no runway. Fourteen properties paid for by the fourteen properties.
What I do
A blood test arrives as a page of numbers and a shrug. You scan it for anything printed in red, decide you are probably fine, and then wait a week to ask somebody who can actually read it. That week is the whole problem.
So I built Kantesti. You upload the page, it reads the numbers, and it tells you in your own language what they say about you, what is normal, what is not, and what is worth asking a doctor about. Two million people have now done that, most of them in a language no health product had bothered to support.
I did it alone. Not as a principle and not as a story. It simply turned out that the fastest way to ship in seventy-five languages was to stop waiting for permission to. There was no round to raise, no roadmap to defend, and nobody to hand the hard part to.
The point of all of it, said plainly, is to raise the quality of health for as many people as possible. A blood test is the cheapest window into a body that medicine has, and most of them are never explained to the person they belong to. That gap is the largest cheap improvement to human health I can find, and closing it is the work. I have been building machine learning since I was twelve, and this is the thirteenth year.
The index
Fourteen properties, in the order they matter
One company, seven European arms, two further companies, three brands and a foundation. The numbering is not decoration. It is the structure.
Parent
The company everything else reports to.
European arms
One country, one language, one name people already trust.
- 02
Mon Bilan Sang - 03
Moje Rozbory - 04
Mio Esame Sangue - 05
Minhas Análises - 06
Mi Análisis de Sangre - 07
AI Bloodtest - 08
Vérkép Elemző
Companies
Separately incorporated, run on the same engine.
Brands
English-language doors into the same engine.
Foundation
The part that does not need a business model.
The company
Kantesti
Everything on this page is either a door into Kantesti Ltd or something that grew out of it.
Kantesti reads a laboratory report the way a patient needs it read, marker by marker, in plain sentences, in the language the report was printed in. It is not a translation layer over an English product. Each country's version was built against that country's own reports, reference ranges and units.
What began in 2019 as a four and a half million parameter model writing two-sentence summaries now runs at 2.78 trillion parameters, and it no longer only summarises. It interprets blood tests and DNA tests, recommends supplements, produces health reports and advises on diet. It works in one hundred and twenty-seven countries and seventy-five languages, and it is paid for entirely by the people who use it.
- LondonRegistered office
- CologneEngineering
- MilanClinical data
- ParisLanguage
- NaplesWhere I write
Programmes
Three partnerships, one membership
There are three technology programmes behind this work, so this section lists three. Nothing here is padding.
- Microsoft for StartupsFounders Hub
Azure credit and the identity stack behind fourteen properties.
- NVIDIA InceptionMember programme
Inference hardware access. Reading a blood panel is cheap, and reading it in seventy-five languages is not.
- Google CloudPartner
Where the multilingual pipeline runs.
Membership
- AIPACMember
American Israel Public Affairs Committee. A membership, held personally rather than by any of the companies listed on this page.
kantesti.org
Kantesti.org is the part that does not need a business model. It supports people who need care anywhere in the world, whatever language they speak, whatever they believe, and wherever they are from.
There is no number worth quoting in this section, so there is not one. It exists because a company that reads two million blood tests should be able to do something for the people behind the ones that came back badly. kantesti.org
On the record
- Legal entity
- Kantesti Ltd
- Companies House
- 17090423
- Jurisdiction
- England & Wales
- Registered name
- Julian Emirhan Bulut
- Wikidata
- Q138690769
Press
Three bios, use whichever fits
Copy buttons, the high-resolution portrait and the logo pack are on the press page.
Short50 words
Julian Emir is the founder of Kantesti Ltd, an AI platform that explains blood test results in more than seventy-five languages. He built it alone and without outside investment. Two million people across one hundred and twenty-seven countries have used it. He works between London and Naples.
Medium100 words
Julian Emir is the founder and chief executive of Kantesti Ltd, a bootstrapped AI platform that reads a laboratory blood test and explains it in the patient's own language. It has been used by more than two million people in one hundred and twenty-seven countries, across more than seventy-five languages, each version built against its own country's laboratory reports rather than translated from English. He runs fourteen properties in total, comprising a parent company, seven European arms, two further companies, three brands and a foundation, with no outside investment and no team. He divides his time between London and Naples.
Long250 words
Julian Emir is the founder and chief executive of Kantesti Ltd, registered in England & Wales as company 17090423. Kantesti is an AI platform that takes a laboratory blood test, the page of numbers most people receive by email and cannot read, and explains it marker by marker in the language the report was printed in.
He has worked with machine learning since the age of twelve, now in his thirteenth year, and began Kantesti in 2019 with a language model of four and a half million parameters, built to write a two-sentence summary of a blood panel. Six years on, that experiment runs at 2.78 trillion parameters and interprets blood tests and DNA tests, recommends supplements, produces health reports and advises on diet.
He built it alone and has never raised outside money. What started as a single tool became fourteen properties, including a global parent company, seven European arms serving France, Czechia, Italy, Portugal, Spain, Germany and Hungary, two separately incorporated companies in Poland and Türkiye, three English-language brands, and a foundation. Each national version was built against that country's own reports, reference ranges and units, on the argument that a translated interface is not the same thing as a local one.
More than two million people in one hundred and twenty-seven countries have used it. The work is supported by Microsoft for Startups, NVIDIA Inception and Google Cloud, and he is a member of AIPAC. He left a degree in artificial intelligence at the University of Milan in 2021 to continue in trade and innovation instead.
His stated aim is to raise the quality of health for as many people as possible, on the argument that a blood test is the cheapest widely available window into a human body and that most are never explained to the person they belong to. He works between London and Naples.
Contact
One address, read by one person. Press, partnerships and anything about the companies above all come here. Other ways to reach me are on the contact page.